LUCENTIX
Lucentix develops a biosensor technology that enables patients to measure concentrations of analytes in a single drop of blood or saliva by using a low-cost handheld device giving laboratory-quality results. The company's biosensors are based on the invention of a new type of biochemical sensing molecule. A light-producing enzyme called luciferase, is engineered to change the color of the emitted light in response to changes in analyte concentration. In absence of the analyte the molecular system emits red light, while at high analyte concentration the light is blue. Lucentix is headquartered in Lausanne, Switzerland.
LUCENTIX
Industry:
Biotechnology Medical Device Sensor
Founded:
2015-01-01
Address:
Lausanne, Vaud, Switzerland
Country:
Switzerland
Website Url:
http://www.lucentix.ch
Status:
Active
Email Addresses:
[email protected]
Total Funding:
130 K CHF
Technology used in webpage:
SPF Zoho Mail Key Systems DNS Key-Systems
Similar Organizations
Merck Accelerator
Merck Accelerator program supports startups in the fields of healthcare, life science, performance materials and additional search fields.
Spero Therapeutics
Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.
Tarsa Therapeutics
Tarsa Therapeutics develops an oral formulation of calcitonin for the treatment and prevention of postmenopausal osteoporosis.
Founder
Investors List
Venture Kick
Venture Kick investment in Pre Seed Round - Lucentix
Venture Kick
Venture Kick investment in Grant - Lucentix
Venture Kick
Venture Kick investment in Grant - Lucentix
Official Site Inspections
http://www.lucentix.ch
- Host name: 104.247.82.51
- IP address: 104.247.82.51
- Location: Canada
- Latitude: 43.6319
- Longitude: -79.3716
- Timezone: America/Toronto
